Biomedical Science Letters

eISSN 2288-7415

Table. 3.

Reduction in MIC after addition of efflux pump inhibitors

Drug No. (%) of isolates with ≥4-fold reduction in MIC No. (%) of isolates with ≥8-fold reduction in MIC
CNAB (n=29) CSAB (n=5) CNAB (n=29) CSAB (n=5)
Meropenem + CCCP 9 2 7 2
Meropenem + PAβN 6 2 3 2
Imipenem + CCCP 10 3 8 2
Imipenem + PAβN 8 2 6 1

CNAB, carbapenem-nonsusceptible A. baumannii; CSAB, carbapenem-susceptible A. baumannii; CCCP, carbonyl cyanide 3-chlorophenylhydrazone; PAβN, phenyl-arginine-β-naphthylamide

Biomed Sci Letters 2021;27:59-68 https://doi.org/10.15616/BSL.2021.27.2.59
© 2021 Biomed Sci Letters